Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Treatment save search
Zhongchao Inc. Promotes Standardized Liver Cancer Diagnosis and Treatment with Medical Associations and Experts
Published: 2021-01-13 (Crawled : 15:00) - biospace.com/
ZCMD | $1.905 31.38% 30M
|
Commercial Services
|
| O: -1.07%
H: 4.86%
C: 2.7%
cancer liver treatment diagnostic
Zhongchao Inc. Builds A Platform for Breast Cancer Tiered Diagnosis and Treatment Improvement To Promote the Equalization of Breast Cancer Diagnosis and Treatment Level
Published: 2021-07-27 (Crawled : 13:00) - prnewswire.com
ZCMD | $1.905 31.38% 30M
|
Commercial Services
|
| O: -1.82%
H: 7.41%
C: 2.78%
treatment cancer breast cancer diagnostic
Zhongchao Inc. Launches Hematology MDT Training Platform to Improve Diagnosis and Treatment
Published: 2021-09-17 (Crawled : 11:00) - prnewswire.com
ZCMD | $1.905 31.38% 30M
|
Commercial Services
|
| O: 1.91%
H: 1.25%
C: 1.25%
treatment diagnostic train
Zhongchao Inc. Announces Its Patient Management System Improves Its Liver Cancer Patients' Duration of Therapy by 40%, Promoting Successful Treatment
Published: 2021-10-29 (Crawled : 11:00) - prnewswire.com
ZCMD | $1.905 31.38% 30M
|
Commercial Services
|
| O: 0.59%
H: 0.0%
C: -2.34%
treatment therapy cancer liver
Zhongchao Inc. Launches Medication Management Assistance Mini Program to Facilitate Cancer Treatment
Published: 2023-01-19 (Crawled : 13:00) - prnewswire.com
ZCMD | $1.905 31.38% 30M
|
Commercial Services
|
| O: 1.25%
H: 0.0%
C: 0.0%
treatment management program cancer
Zhongchao Inc. Launch Digital Online Education Platform for Common Diseases Clinical Diagnosis and Treatment
Published: 2023-06-12 (Crawled : 12:00) - prnewswire.com
ZCMD | $1.905 31.38% 30M
|
Commercial Services
|
| O: -0.89%
H: 2.7%
C: 2.7%
treatment education platform
INVO Bioscience Eyes +20 U.S. Cities To Expand Rollout Of Advanced Infertility Treatment 'INVO Centers'
Published: 2022-02-09 (Crawled : 13:30) - biospace.com/
INVO | $1.32 -13.16% 1.1M
|
Health Technology
|
| O: 0.92%
H: 3.96%
C: 1.22%
treatment eye yes bioscience
New Birmingham INVO Center Offers Families an Affordable Advanced Fertility Treatment Solution to Help Combat Rising Costs
Published: 2022-03-10 (Crawled : 14:00) - invobioscience.com
INVO | $1.32 -13.16% 1.1M
|
Health Technology
|
| O: -9.94%
H: 4.11%
C: 0.0%
treatment ford
Benitec Biopharma Receives FDA Clearance of the IND for BB-301 for the Treatment of Oculopharyngeal Muscular Dystrophy
Published: 2023-06-26 (Crawled : 12:00) - ir.benitec.com
BNTC | News | $6.835 0.22% 160K
|
Health Technology
|
| O: 49.25%
H: 78.45%
C: 21.21%
bb-301 fda treatment biopharma clearance
Benitec Biopharma Announces First Subject Dosed in Phase 1b/2a Clinical Trial for Gene Therapy Candidate BB-301 for the Treatment of Oculopharyngeal Muscular Dystrophy
Published: 2023-11-30 (Crawled : 15:30) - biospace.com/
BNTC | News | $6.835 0.22% 160K
|
Health Technology
|
| O: 4.58%
H: 8.29%
C: -0.63%
bb-301 candidate treatment biopharma trial therapy
Portage Biotech Highlights First Patient Dosed in IMP-MEL Study of PORT-2 for the Treatment of Melanoma and Non-Small Cell Lung Cancer (NSCLC)
Published: 2021-08-05 (Crawled : 12:00) - globenewswire.com
PRTG | $0.28 16.67% 220K
|
Mining, Quarrying, and Oil and ...
|
| O: 1.25%
H: 13.6%
C: 12.88%
treatment lung cancer cancer biotech iot
Portage Biotech Highlights First Patient Dosed in PRECIOUS-01 Study of PORT-3 for the Treatment of NY-ESO-1 Positive Solid Tumors
Published: 2021-04-08 (Crawled : 15:00) - biospace.com/
PRTG | $0.28 16.67% 220K
|
Mining, Quarrying, and Oil and ...
|
| O: 0.0%
H: 2.26%
C: -3.87%
treatment solid tumors positive biotech iot
Portage Biotech Reports Updated Interim Data for Lead iNKT Engager, PORT-2, in a Phase 1/2 Trial for the Treatment of Advanced Melanoma and Metastatic Non-Small Cell Lung Cancer at the 2023 American Society for Clinical Oncology (ASCO) Annual Meeting
Published: 2023-06-05 (Crawled : 12:20) - globenewswire.com
PRTG | $0.28 16.67% 220K
|
Mining, Quarrying, and Oil and ...
|
| O: 2.47%
H: 17.65%
C: 0.8%
lung melanoma biotech cancer cell treatment meeting trial
Bio-Path Holdings to Host Virtual Key Opinion Leader Event to Discuss Prexigebersen and Advances in the Treatment Landscape for Acute Myeloid Leukemia
Published: 2023-10-24 (Crawled : 11:00) - globenewswire.com
BPTH | News 0 d | $4.29 2.14% 1.8M
|
Health Technology
|
| O: 0.0%
H: 11.96%
C: 10.36%
treatment leukemia
Regencell Bioscience Holdings Limited Establishes a Joint Venture to Offer COVID Treatment
Published: 2021-09-02 (Crawled : 14:00) - biospace.com/
RGC | $5.22 620
|
Manufacturing
|
| O: 5.28%
H: 9.58%
C: -8.44%
covid treatment bioscience
Eledon Pharmaceuticals Announces Publication of Data Showing Treatment with Tegoprubart Promotes Kidney and Islet Allograft Survival and Function in Nonhuman Primates
Published: 2023-09-06 (Crawled : 11:00) - globenewswire.com
ELDN | $1.82 -8.54% 320K
|
Manufacturing
|
| O: 18.88%
H: 0.0%
C: -25.88%
kidney publication treatment pharmaceuticals
Amyotrophic Lateral Sclerosis Treatment Market size to grow by USD 663.7 million from 2023 to 2028, North America to account for 42% of market growth - Technavio
Published: 2023-12-07 (Crawled : 00:00) - prnewswire.com
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 2.06%
H: 0.82%
C: 0.82%
ELDN | $1.82 -8.54% 320K
|
Manufacturing
|
| O: -1.59%
H: 7.26%
C: 2.42%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: 1.07%
H: 0.0%
C: 0.0%
DNLI | $16.1 -3.01% 280K
|
Health Technology
|
| O: -0.21%
H: 0.08%
C: -1.76%
BCLI | $0.54 5.0% 940K
|
Health Technology
|
| O: 0.0%
H: 3.56%
C: -9.77%
BIIB | $192.68 1.13% 590K
|
Health Technology
|
| O: -0.61%
H: 1.33%
C: 0.69%
america sclerosis treatment growth market
Amyotrophic Lateral Sclerosis Treatment Market size to grow by USD 663.7 million, 42% of market growth is expected in North America, Technavio
Published: 2024-03-12 (Crawled : 04:00) - prnewswire.com
ELDN | $1.82 -8.54% 320K
|
Manufacturing
|
| O: 1.73%
H: 1.7%
C: -7.39%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: 0.01%
H: 0.0%
C: 0.0%
DNLI | $16.1 -3.01% 280K
|
Health Technology
|
| O: -0.6%
H: 0.74%
C: -3.66%
BCLI | $0.54 5.0% 940K
|
Health Technology
|
| O: -2.43%
H: 2.8%
C: -4.02%
BIIB | $192.68 1.13% 590K
|
Health Technology
|
| O: -0.32%
H: 0.18%
C: -0.86%
expected sclerosis treatment growth market
FDA Grants Orphan Drug Designation to Temferon for Treatment of Glioblastoma Multiforme
Published: 2023-03-02 (Crawled : 12:00) - globenewswire.com
GNTA | $3.9156 5.5K
|
n/a
|
| O: 11.5%
H: 0.0%
C: -6.78%
treatment fda designation drug grants glioblastoma
Genenta Update at SITC22 Indicates Potential for Anti-Tumor Immune System Reset after Temferon™ Treatment in Glioblastoma Patients
Published: 2022-11-07 (Crawled : 13:20) - globenewswire.com
GNTA | $3.9156 5.5K
|
n/a
|
| O: 9.27%
H: 0.45%
C: -0.59%
sitc22 treatment system potential update glioblastoma
Gainers vs Losers
| 73% | 27% |
Top 10 Gainers
AGBA | News | $1.27 217.5% 120M
|
Finance
EGOX | $0.054 50.0% 290M
|
RWOD | $10.52 31.56% 5.9M
|
n/a
ZCMD | $1.905 31.38% 30M
|
Commercial Services
NVFY | $2.71 28.44% 31M
|
Consumer Durables
MRDB 4 | $0.536 27.65% 2M
|
n/a
BSFC | $0.0822 27.64% 75M
|
Manufacturing
INDO | $5.1 25.0% 15M
|
Energy Minerals
CHRO | $1.53 24.9% 100K
|
n/a
AULT | $0.2998 23.83% 53M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.